Medicamen Biotech share news, announcements and annual reports
NSE: MEDICAMEQBSE: 531146Pharmaceuticals & BiotechnologySmall Cap
Medicamen Biotech Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1995 on BSE, Oct 2021 on NSE
Last close ₹260.10up ₹3.90 (1.52%)BSE ₹264.25
Share price at the NSE close on 2 Nov 2026. Previous close ₹256.20.
2 Nov: open ₹254.00, high ₹264.65, low ₹251.10
52-week range of traded prices to 2 Nov 2026
₹212.40Low, 29 Jun 2026₹447.65High, 25 Nov 2025
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹366 Cr1,991st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.33
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.38%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 3.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.17
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 5,588
Medicamen Biotech routine notices
80 filed, newest first. Page 2 of 2.
May 2023
Apr 2023
1 Apr · Routine
Mar 2023
3 Mar · Routine
Feb 2023
13 Feb · Routine
3 Feb · Routine
Jan 2023
24 Jan · Routine
Dec 2022
29 Dec · Routine
29 Dec · Routine
Nov 2022
15 Nov · Routine
4 Nov · Routine
4 Nov · Routine
Oct 2022
1 Oct · Routine
Sep 2022
Aug 2022
20 Aug · Routine
5 Aug · Routine
Jul 2022
2 Jul · Routine
May 2022
30 May · Routine
26 May · Routine
Apr 2022
Mar 2022
10 Mar · Routine
10 Mar · Routine
Feb 2022
10 Feb · Routine
Jan 2022
17 Jan · Routine
Dec 2021
Nov 2021
8 Nov · Routine